INSPIRA™ ART100
Blood oxygenation / cardiopulmonary bypass
FDA cleared (510(k))Commercial (limited)
Key Facts
Indication
Blood oxygenation / cardiopulmonary bypass
Phase
FDA cleared (510(k))
Status
Commercial (limited)
Company
About Inspira Technologies
Innovative non‑invasive respiratory support platform that could replace mechanical ventilators in critical care.
View full company profile